Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Nabiximols is Efficient as Add-On Treatment for Patients wit — 2023 Clinical Trial | BudProfiles

Home

Studies

Nabiximols is Efficient as Add-On Treatment for Pa...

PositiveClinical Trial2023

Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Multiple Sclerosis

Related Studies

Positive

Unraveling endocannabinoid signaling disruption in a preclinical model of neurodevelopmental disorders

2025·Review/Other

N/A

Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review

2025·Review/Other

N/A

The use of cannabidiol (CBD) to improve sleep: a systematic review

2025·Meta-analysis -

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Region-Specific Impact of Repeated Synthetic Cannabinoid Exposure and Withdrawal on Endocannabinoid Signaling, Gliosis, and Inflammatory Markers in the Prefrontal Cortex and Hippocampus

2025·Review/Other

Cannabinoids

CBDPharma THC:CBDTHC

Organ Systems

Nervous System

Study Details

Type: Clinical Trial
Year: 2023
Study ID: #2023042